$PCRX
Pacira BioSciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$25.20
▲+1.78%+$0.440
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePacira BioSciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PCRX up today? It is at $25.20 (+1.78%), and our scanner flagged it 41 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PCRX spikes, and full due diligence on PCRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PCRX 41 times in the last 30 days. Create a free account to track $PCRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPacira BioSciences, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 18, 2026 · 50 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Slonin Jonathan Officer | Sold (automatic/other) | -3K | sold 1.4% | 216K | $71K at $23.23 | Aug 17, 26 |
Riker Lauren Officer | Sold (automatic/other) | -6K 0.02% of company | sold 8.9% | 62K | $144K at $23.50 | Jun 11, 26 |
Froimson Mark Director | Acquired (grant/award) | +6K 0.02% of company | added 32% | 27K | n/a | Jun 10, 26 |
Brege Laura Director | Acquired (grant/award) | +6K 0.02% of company | added 27% | 30K | n/a | Jun 10, 26 |
Bigal Marcelo Director | Acquired (grant/award) | +6K 0.02% of company | added 56% | 18K | n/a | Jun 10, 26 |
Yang Michael J. Director | Acquired (grant/award) | +6K 0.02% of company | added 48% | 20K | n/a | Jun 10, 26 |
Young Alethia Director | Acquired (grant/award) | +6K 0.02% of company | added 56% | 18K | n/a | Jun 10, 26 |
Christie Christopher Director | Acquired (grant/award) | +6K 0.02% of company | added 38% | 23K | n/a | Jun 10, 26 |
Hirawat Samit Director | Acquired (grant/award) | +6K 0.02% of company | n/a | 6K | n/a | Jun 10, 26 |
Williams Kristen Officer | Sold (automatic/other) | -10K 0.03% of company | sold 5.8% | 167K | $228K at $22.27 | Jun 4, 26 |
Williams Kristen Officer | Sold (automatic/other) | -9K 0.02% of company | sold 4.6% | 177K | $190K at $22.32 | Jun 3, 26 |
Slonin Jonathan Officer | Sold (automatic/other) | -5K 0.01% of company | sold 2.1% | 219K | $106K at $22.32 | Jun 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PCRX last traded at $25.20, up 1.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pacira BioSciences, Inc. Common Stock (PCRX) is next expected to report earnings on Thursday, November 5, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PCRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PCRX 41 times in the last 30 days.
PCRX (Pacira BioSciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.00B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PCRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PCRX discussion
Sign in to ask a question or join the discussion.